Compile Data Set for Download or QSAR
maximum 50k data
Found 126 Enz. Inhib. hit(s) with all data for entry = 56
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113060(US9695194, 1)
Affinity DataKi:  48nM ΔG°:  -43.5kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Recombinant human KLK7, Substrate S-2586 (Chromogenics, cat. no. 820894) KLK7 activity was determined at 37° C. in 10 mM Na phosphate ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113283(US9695194, 8)
Affinity DataKi:  65nM ΔG°:  -42.7kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Recombinant human KLK7, Substrate S-2586 (Chromogenics, cat. no. 820894) KLK7 activity was determined at 37° C. in 10 mM Na phosphate ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113065(US9695194, 2)
Affinity DataKi:  73nM ΔG°:  -42.4kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Recombinant human KLK7, Substrate S-2586 (Chromogenics, cat. no. 820894) KLK7 activity was determined at 37° C. in 10 mM Na phosphate ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113119(US9695194, 6)
Affinity DataKi:  80nM ΔG°:  -42.1kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Recombinant human KLK7, Substrate S-2586 (Chromogenics, cat. no. 820894) KLK7 activity was determined at 37° C. in 10 mM Na phosphate ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113069(US9695194, 5)
Affinity DataKi:  85nM ΔG°:  -42.0kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Recombinant human KLK7, Substrate S-2586 (Chromogenics, cat. no. 820894) KLK7 activity was determined at 37° C. in 10 mM Na phosphate ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113248(US9695194, 7)
Affinity DataKi:  90nM ΔG°:  -41.8kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Recombinant human KLK7, Substrate S-2586 (Chromogenics, cat. no. 820894) KLK7 activity was determined at 37° C. in 10 mM Na phosphate ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymotrypsin-C(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113248(US9695194, 7)
Affinity DataKi: <100nM ΔG°: <-41.6kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Chymotrypsin, bovine, 25 ug (Roche, sequence grade), Substrate S-2586 (Chromogenics, cat. no. 82 08 94). Chymotrypsin activity was determi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymotrypsin-C(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113119(US9695194, 6)
Affinity DataKi: <100nM ΔG°: <-41.6kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Chymotrypsin, bovine, 25 ug (Roche, sequence grade), Substrate S-2586 (Chromogenics, cat. no. 82 08 94). Chymotrypsin activity was determi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-14(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113065(US9695194, 2)
Affinity DataKi:  100nM ΔG°:  -41.6kJ/molepH: 8.0 T: 2°CAssay Description:Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM50289001(2-(2-Iodo-phenyl)-6,7-dimethoxy-benzo[d][1,3]oxazi...)
Affinity DataKi:  100nM ΔG°:  -41.6kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Recombinant human KLK7, Substrate S-2586 (Chromogenics, cat. no. 820894) KLK7 activity was determined at 37° C. in 10 mM Na phosphate ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-14(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113060(US9695194, 1)
Affinity DataKi:  100nM ΔG°:  -41.6kJ/molepH: 8.0 T: 2°CAssay Description:Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin G(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113301(US9695194, 17)
Affinity DataKi:  100nM ΔG°:  -41.6kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Cathepsin G, 100 mU (VWR, Calbiochem, cat. no. 219373), Substrate Cathepsin G substrate (VWR, Calbiochem, cat. no. 219407). Cathepsin acti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymotrypsin-C(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113300(US9695194, 16)
Affinity DataKi: <100nM ΔG°: <-41.6kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Chymotrypsin, bovine, 25 ug (Roche, sequence grade), Substrate S-2586 (Chromogenics, cat. no. 82 08 94). Chymotrypsin activity was determi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymotrypsin-C(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113299(US9695194, 15)
Affinity DataKi: <100nM ΔG°: <-41.6kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Chymotrypsin, bovine, 25 ug (Roche, sequence grade), Substrate S-2586 (Chromogenics, cat. no. 82 08 94). Chymotrypsin activity was determi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetChymotrypsin-C(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113297(US9695194, 14)
Affinity DataKi: <100nM ΔG°: <-41.6kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Chymotrypsin, bovine, 25 ug (Roche, sequence grade), Substrate S-2586 (Chromogenics, cat. no. 82 08 94). Chymotrypsin activity was determi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymotrypsin-C(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113296(US9695194, 13)
Affinity DataKi: <100nM ΔG°: <-41.6kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Chymotrypsin, bovine, 25 ug (Roche, sequence grade), Substrate S-2586 (Chromogenics, cat. no. 82 08 94). Chymotrypsin activity was determi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymotrypsin-C(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113283(US9695194, 8)
Affinity DataKi: <100nM ΔG°: <-41.6kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Chymotrypsin, bovine, 25 ug (Roche, sequence grade), Substrate S-2586 (Chromogenics, cat. no. 82 08 94). Chymotrypsin activity was determi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113299(US9695194, 15)
Affinity DataKi:  105nM ΔG°:  -41.4kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Recombinant human KLK7, Substrate S-2586 (Chromogenics, cat. no. 820894) KLK7 activity was determined at 37° C. in 10 mM Na phosphate ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113067(US9695194, 3)
Affinity DataKi:  116nM ΔG°:  -41.2kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Recombinant human KLK7, Substrate S-2586 (Chromogenics, cat. no. 820894) KLK7 activity was determined at 37° C. in 10 mM Na phosphate ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113295(US9695194, 12)
Affinity DataKi:  147nM ΔG°:  -40.6kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Recombinant human KLK7, Substrate S-2586 (Chromogenics, cat. no. 820894) KLK7 activity was determined at 37° C. in 10 mM Na phosphate ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113300(US9695194, 16)
Affinity DataKi:  149nM ΔG°:  -40.5kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Recombinant human KLK7, Substrate S-2586 (Chromogenics, cat. no. 820894) KLK7 activity was determined at 37° C. in 10 mM Na phosphate ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113296(US9695194, 13)
Affinity DataKi:  155nM ΔG°:  -40.4kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Recombinant human KLK7, Substrate S-2586 (Chromogenics, cat. no. 820894) KLK7 activity was determined at 37° C. in 10 mM Na phosphate ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113301(US9695194, 17)
Affinity DataKi:  175nM ΔG°:  -40.1kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Recombinant human KLK7, Substrate S-2586 (Chromogenics, cat. no. 820894) KLK7 activity was determined at 37° C. in 10 mM Na phosphate ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113297(US9695194, 14)
Affinity DataKi:  183nM ΔG°:  -40.0kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Recombinant human KLK7, Substrate S-2586 (Chromogenics, cat. no. 820894) KLK7 activity was determined at 37° C. in 10 mM Na phosphate ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113293(US9695194, 10)
Affinity DataKi:  188nM ΔG°:  -39.9kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Recombinant human KLK7, Substrate S-2586 (Chromogenics, cat. no. 820894) KLK7 activity was determined at 37° C. in 10 mM Na phosphate ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin G(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113297(US9695194, 14)
Affinity DataKi:  200nM ΔG°:  -39.8kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Cathepsin G, 100 mU (VWR, Calbiochem, cat. no. 219373), Substrate Cathepsin G substrate (VWR, Calbiochem, cat. no. 219407). Cathepsin acti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-5 [D153N](Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113060(US9695194, 1)
Affinity DataKi:  200nM ΔG°:  -39.8kJ/molepH: 8.0 T: 2°CAssay Description:Materials: Recombinant human KLK5, Substrate S-2288 (Chromogenics, cat. no. 820852) KLK5 activity was determined at 37° C. in 0.1 M Tris, pH 8.0,...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymotrypsin-C(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113293(US9695194, 10)
Affinity DataKi:  200nM ΔG°:  -39.8kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Chymotrypsin, bovine, 25 ug (Roche, sequence grade), Substrate S-2586 (Chromogenics, cat. no. 82 08 94). Chymotrypsin activity was determi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113292(US9695194, 9)
Affinity DataKi:  228nM ΔG°:  -39.4kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Recombinant human KLK7, Substrate S-2586 (Chromogenics, cat. no. 820894) KLK7 activity was determined at 37° C. in 10 mM Na phosphate ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-7(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113068(US9695194, 4)
Affinity DataKi:  230nM ΔG°:  -39.4kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Recombinant human KLK7, Substrate S-2586 (Chromogenics, cat. no. 820894) KLK7 activity was determined at 37° C. in 10 mM Na phosphate ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-14(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113069(US9695194, 5)
Affinity DataKi:  300nM ΔG°:  -38.7kJ/molepH: 8.0 T: 2°CAssay Description:Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin G(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113300(US9695194, 16)
Affinity DataKi:  400nM ΔG°:  -38.0kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Cathepsin G, 100 mU (VWR, Calbiochem, cat. no. 219373), Substrate Cathepsin G substrate (VWR, Calbiochem, cat. no. 219407). Cathepsin acti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymotrypsin-C(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113292(US9695194, 9)
Affinity DataKi:  400nM ΔG°:  -38.0kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Chymotrypsin, bovine, 25 ug (Roche, sequence grade), Substrate S-2586 (Chromogenics, cat. no. 82 08 94). Chymotrypsin activity was determi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-5 [D153N](Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113069(US9695194, 5)
Affinity DataKi:  500nM ΔG°:  -37.4kJ/molepH: 8.0 T: 2°CAssay Description:Materials: Recombinant human KLK5, Substrate S-2288 (Chromogenics, cat. no. 820852) KLK5 activity was determined at 37° C. in 0.1 M Tris, pH 8.0,...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-14(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113067(US9695194, 3)
Affinity DataKi:  500nM ΔG°:  -37.4kJ/molepH: 8.0 T: 2°CAssay Description:Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-5 [D153N](Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113065(US9695194, 2)
Affinity DataKi:  500nM ΔG°:  -37.4kJ/molepH: 8.0 T: 2°CAssay Description:Materials: Recombinant human KLK5, Substrate S-2288 (Chromogenics, cat. no. 820852) KLK5 activity was determined at 37° C. in 0.1 M Tris, pH 8.0,...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin G(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113293(US9695194, 10)
Affinity DataKi:  500nM ΔG°:  -37.4kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Cathepsin G, 100 mU (VWR, Calbiochem, cat. no. 219373), Substrate Cathepsin G substrate (VWR, Calbiochem, cat. no. 219407). Cathepsin acti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin G(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113299(US9695194, 15)
Affinity DataKi:  500nM ΔG°:  -37.4kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Cathepsin G, 100 mU (VWR, Calbiochem, cat. no. 219373), Substrate Cathepsin G substrate (VWR, Calbiochem, cat. no. 219407). Cathepsin acti...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetKallikrein-14(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113299(US9695194, 15)
Affinity DataKi:  500nM ΔG°:  -37.4kJ/molepH: 8.0 T: 2°CAssay Description:Materials: Recombinant human KLK14, Substrate S-2302 (Chromogenics, cat. no. 820340). KLK14 activity was determined at 37° C. in 0.1 mM Tris, pH ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetKallikrein-5 [D153N](Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113299(US9695194, 15)
Affinity DataKi:  500nM ΔG°:  -37.4kJ/molepH: 8.0 T: 2°CAssay Description:Materials: Recombinant human KLK5, Substrate S-2288 (Chromogenics, cat. no. 820852) KLK5 activity was determined at 37° C. in 0.1 M Tris, pH 8.0,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113293(US9695194, 10)
Affinity DataKi:  500nM ΔG°:  -37.4kJ/molepH: 8.3 T: 2°CAssay Description:Materials: Thrombin (Chromogenics, cat. no. 820712), Substrate S-2288 (Chromogenics, cat. no. 82 08 52). Thrombin activity was determined at 37° ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113248(US9695194, 7)
Affinity DataKi:  500nM ΔG°:  -37.4kJ/molepH: 8.3 T: 2°CAssay Description:Materials: Thrombin (Chromogenics, cat. no. 820712), Substrate S-2288 (Chromogenics, cat. no. 82 08 52). Thrombin activity was determined at 37° ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-5 [D153N](Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113067(US9695194, 3)
Affinity DataKi:  600nM ΔG°:  -36.9kJ/molepH: 8.0 T: 2°CAssay Description:Materials: Recombinant human KLK5, Substrate S-2288 (Chromogenics, cat. no. 820852) KLK5 activity was determined at 37° C. in 0.1 M Tris, pH 8.0,...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-5 [D153N](Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113297(US9695194, 14)
Affinity DataKi:  600nM ΔG°:  -36.9kJ/molepH: 8.0 T: 2°CAssay Description:Materials: Recombinant human KLK5, Substrate S-2288 (Chromogenics, cat. no. 820852) KLK5 activity was determined at 37° C. in 0.1 M Tris, pH 8.0,...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113119(US9695194, 6)
Affinity DataKi:  600nM ΔG°:  -36.9kJ/molepH: 8.3 T: 2°CAssay Description:Materials: Thrombin (Chromogenics, cat. no. 820712), Substrate S-2288 (Chromogenics, cat. no. 82 08 52). Thrombin activity was determined at 37° ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetKallikrein-5 [D153N](Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113296(US9695194, 13)
Affinity DataKi:  600nM ΔG°:  -36.9kJ/molepH: 8.0 T: 2°CAssay Description:Materials: Recombinant human KLK5, Substrate S-2288 (Chromogenics, cat. no. 820852) KLK5 activity was determined at 37° C. in 0.1 M Tris, pH 8.0,...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113300(US9695194, 16)
Affinity DataKi:  600nM ΔG°:  -36.9kJ/molepH: 8.3 T: 2°CAssay Description:Materials: Thrombin (Chromogenics, cat. no. 820712), Substrate S-2288 (Chromogenics, cat. no. 82 08 52). Thrombin activity was determined at 37° ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin G(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113283(US9695194, 8)
Affinity DataKi:  600nM ΔG°:  -36.9kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Cathepsin G, 100 mU (VWR, Calbiochem, cat. no. 219373), Substrate Cathepsin G substrate (VWR, Calbiochem, cat. no. 219407). Cathepsin acti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetChymotrypsin-C(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113295(US9695194, 12)
Affinity DataKi:  600nM ΔG°:  -36.9kJ/molepH: 7.2 T: 2°CAssay Description:Materials: Chymotrypsin, bovine, 25 ug (Roche, sequence grade), Substrate S-2586 (Chromogenics, cat. no. 82 08 94). Chymotrypsin activity was determi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProthrombin(Homo sapiens (Human))
Sixera Pharma

US Patent
LigandPNGBDBM113299(US9695194, 15)
Affinity DataKi:  600nM ΔG°:  -36.9kJ/molepH: 8.3 T: 2°CAssay Description:Materials: Thrombin (Chromogenics, cat. no. 820712), Substrate S-2288 (Chromogenics, cat. no. 82 08 52). Thrombin activity was determined at 37° ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 126 total ) | Next | Last >>
Jump to: